Wejse, C., Gomes, V. F., Rabna, P., Gustafson, P., Aaby, P., Lisse, I. M.
, Andersen, P. L., Glerup, H. & Sodemann, M. (2009).
Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.
American Journal of Respiratory and Critical Care Medicine,
179(9), 843-50.
https://doi.org/10.1164/rccm.200804-567OC
Viard, J.-P., Souberbielle, J.-C., Kirk, O., Reekie, J., Knysz, B., Losso, M., Gatell, J., Pedersen, C., Bogner, J. R., Lundgren, J. D., Mocroft, A. & EuroSIDA Study Group (Lars Østergaard, member) (2011).
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study.
AIDS,
25(10), 1305-15.
https://doi.org/10.1097/QAD.0b013e328347f6f7
Nordholm, A. C., Ravn, P., Kristensen, K. L., Nygaard, U., Jensen, S. G.
, Wejse, C., Andersen, Å. B. & Lillebæk, T. (2019).
Vi skal blive bedre til at teste for latent tuberkulose i Danmark.
Ugeskrift for Læger,
181(48), Artikel V09190494 .
Lohse, N., Kronborg, G., Gerstoft, J.
, Larsen, C. S., Pedersen, G., Pedersen, C.
& Sørensen, H. T. (2006).
Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
Clinical Infectious Disease,
42, 136-44.
Laursen, A. L., Ingerslev, J., Andersen, P. L. & Ostergaard, L. (1998).
Viremia in chronic hepatitis C patients evaluated by the Amplicor RT-PCR, a nested RT-PCR, and transaminase levels.
APMIS Supplementum,
106, 334-8.
https://doi.org/10.1111/j.1699-0463.1998.tb01354.x
Fox, Z., Phillips, A., Cohen, C., Neuhaus, J., Baxter, J., Emery, S., Hirschel, B., Hullsiek, K. H., Stephan, C., Lundgren, J., SMART Study Group
& Østergaard, L. J. (2008).
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.
AIDS,
22(17), 2279-89.
https://doi.org/10.1097/QAD.0b013e328311d16f
Kirk, N. V., Jensen, J. M. B., Petersen, M. S., Al-Mousawi, A., Mogensen, T. H., Christiansen, M. & Larsen, C. S. (2021).
Very early onset inflammatory bowel disease with compound heterozygous variants in Nuclear Factor of Activated T cell 5.
European Journal of Immunology,
51(4), 999-1001.
https://doi.org/10.1002/eji.202048602